Alnylam Pharma Beats Inventorship Suit Tied To COVID-19 Jab
By Lauren Berg · July 1, 2025, 11:38 PM EDT
A Delaware federal judge Tuesday tossed Acuitas Therapeutics' lawsuit seeking to have its scientists added as inventors on seven Alnylam Pharmaceuticals patents tied to mRNA technology, saying the complaint doesn't plausibly...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login